Doximity Inc

DOCS

Equity

ISIN US26622P1075 / Valor 111921599

New York Stock Exchange, Inc (2024-09-18)

USD 40.06-0.25%

Doximity Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Doximity Inc is a health tech company founded by industry veterans with backgrounds in institutions like Cleveland Clinic and Stanford University. Led by CEO Jeff Tangney, who previously founded Epocrates, and co-founder Dr. Nate Gross, who previously founded Rock Health, the company is supported by a team of experts and investors in the healthcare industry. With a focus on connecting healthcare professionals and providing digital health solutions, Doximity Inc aims to revolutionize the way medical professionals collaborate and access information.

Summarized from source with an LLMView SourceSector: Technology

Revenue Growth

Doximity Inc. reported revenue of $118.1 million for the fourth quarter of fiscal year 2024, marking a 6% increase compared to the same period in the previous year. For the entire fiscal year 2024, the company achieved total revenues of $475.4 million, which represents a 13% year-over-year growth.

Net Income

In the fourth quarter of fiscal year 2024, Doximity Inc. recorded a net income of $40.6 million, up from $30.7 million in the same quarter of the previous year, reflecting a 32% increase. For the full fiscal year 2024, net income grew by 31% year-over-year, reaching $147.6 million.

Adjusted EBITDA

Doximity Inc. reported an adjusted EBITDA of $56.4 million for the fourth quarter of fiscal year 2024, a 15% increase from the $48.9 million reported in the same quarter of the previous year. For the full fiscal year 2024, adjusted EBITDA grew by 25% year-over-year, totaling $230.5 million.

Cash Flow

Operating cash flow for Doximity Inc. in the fourth quarter of fiscal year 2024 was $63.9 million, a 37% increase from $46.6 million in the same period of the previous year. Free cash flow also saw a 37% year-over-year increase, reaching $62.3 million for the quarter.

Financial Outlook

For the first quarter of fiscal year 2025, Doximity Inc. projects revenue between $119.5 million and $120.5 million, with adjusted EBITDA expected to be between $55 million and $56 million. For the full fiscal year 2025, the company anticipates revenue between $506 million and $518 million, and adjusted EBITDA between $238 million and $250 million.

Summarized from source with an LLMView Source

Key figures

93.0%1Y

-58.1%3Y

%5Y

Performance

51.5%1Y

65.6%3Y

69.7%5Y

Volatility